-
A new class of oral hypoglycemic drugs - SGLT-2 inhibitors
Aug , 17 2021
SGLT-2 inhibitors, sodium-glucose cotransporter 2 inhibitors, are a new class of oral hypoglycemic drugs. This kind of drugs include empagliflozin(CAS No.: 864070-44-0), dapagliflozin(CAS No.: 864070-...
read more
-
Research from Tsinghua University has shown that NMN can treat inflammation without side effects
Sep , 24 2021
Studies have shown that inflammation in any part of the body will activate macrophages, and macrophages will secrete more inflammation-inducing substances to drive chronic inflammation. This vicious c...
read more
-
Common functional ingredients in the female health care market-1 Hormone adjustment
Oct , 11 2021
1. PMS, physiological pain Premenstrual syndrome, referred to as PMS, refers to women of childbearing age who repeatedly experience a series of mental, behavioral, and physical symptoms 7 to 14 days b...
read more
-
Brief introduction of Nano-active Astaxanthin
May , 10 2023
Astaxanthin is a carotenoid with strong antioxidant activity, 100 times higher than that of vitamin E. Therefore, astaxanthin is now widely used in high-end cosmetics and skin care products with anti-...
read more
-
CDMO Projects from Continuous Flow Technology
May , 22 2023
Continuous flow technology is becoming a strategic investment field of the world pharmaceutical group and CDMO. Large international pharmaceutical groups have applied continuous flow technology to the...
read more
-
2'-fucosyllactose, a new choice of healthy food
Dec , 19 2023
2'-fucosyllactose(2'-FL) is a type of sugar that is a derivative of lactose. It contains fucose, a sugar that is abundant in seaweed, and lactose, the sugar in milk. 2'-fucosyllactose is a rare disacc...
read more
-
Industrialization Status of 2'-Fucosyllactose (2'-FL)
May , 13 2024
2'-FL (2'-Fucosyllactose), a prominent constituent of neutral fucosylated Human Milk Oligosaccharides (HMOs), is most abundantly found in human breast milk. Renowned for its diverse functional attribu...
read more
-
EU's Approval of Novel HMOs Ingredients Including 2'-FL, 3-FL, and 6'-SL for Food Applications
Jul , 09 2024
In recent years, the European Union (EU) has paid particular attention to the category of Novel Foods during its approval process, with a focus on Human Milk Oligosaccharides (HMOs). HMOs, as crucial ...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
